PHARMADANICA A/S — Credit Rating and Financial Key Figures
CVR number: 19056007
Vassingerødvej 9, 3540 Lynge
info@missionpharma.com
tel: 48163248
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| External services | -11.05 | -20.28 | -11.77 | -33.06 | -26.40 |
| Gross profit | -11.05 | -20.28 | -11.77 | -33.06 | -26.40 |
| EBIT | -11.05 | -20.28 | -11.77 | -33.06 | -26.40 |
| Other financial income | 132.23 | 45.12 | 490.82 | 106.80 | 143.19 |
| Other financial expenses | - 898.99 | - 825.92 | -1.46 | -1 131.79 | - 132.66 |
| Pre-tax profit | - 777.71 | - 801.08 | 477.60 | -1 058.04 | -15.86 |
| Income taxes | 0.70 | 8.71 | -1.64 | 3.14 | 0.81 |
| Net earnings | - 777.01 | - 792.36 | 475.96 | -1 054.91 | -15.05 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Other tangible assets | 19 549.07 | 18 417.63 | 18 284.97 | ||
| Tangible assets total | 19 549.07 | 18 417.63 | 18 284.97 | ||
| Other non-current investments | 19 169.41 | ||||
| Investments total | 19 169.41 | ||||
| Non-current loans receivable | 19 976.00 | ||||
| Long term receivables total | 19 976.00 | ||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 9.76 | 18.47 | 16.84 | 19.98 | |
| Current other receivables | -0.10 | ||||
| Current deferred tax assets | 23.51 | ||||
| Short term receivables total | 9.66 | 18.47 | 16.84 | 19.98 | 23.51 |
| Cash and bank deposits | 414.97 | 430.38 | 538.32 | 640.46 | 729.67 |
| Cash and cash equivalents | 414.97 | 430.38 | 538.32 | 640.46 | 729.67 |
| Balance sheet total (assets) | 20 400.63 | 19 618.27 | 20 104.23 | 19 078.07 | 19 038.15 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 1 000.00 | 1 000.00 | 1 000.00 | 1 000.00 | 1 000.00 |
| Shares repurchased | 500.00 | ||||
| Retained earnings | 18 649.37 | 17 872.36 | 17 080.00 | 17 555.96 | 16 001.05 |
| Profit of the financial year | - 777.01 | - 792.36 | 475.96 | -1 054.91 | -15.05 |
| Shareholders equity total | 18 872.36 | 18 080.00 | 18 555.96 | 17 501.05 | 17 486.00 |
| Non-current liabilities total | |||||
| Current owed to group member | 1 518.27 | 1 528.27 | 1 538.27 | 1 548.27 | 1 527.48 |
| Other non-interest bearing current liabilities | 10.00 | 10.00 | 10.00 | 28.75 | 24.67 |
| Current liabilities total | 1 528.27 | 1 538.27 | 1 548.27 | 1 577.02 | 1 552.15 |
| Balance sheet total (liabilities) | 20 400.63 | 19 618.27 | 20 104.23 | 19 078.07 | 19 038.15 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.